Sunshine Biopharma (SBFM) Depreciation & Amortization - Total (2019 - 2025)
Historic Depreciation & Amortization - Total for Sunshine Biopharma (SBFM) over the last 7 years, with Q3 2025 value amounting to $95821.0.
- Sunshine Biopharma's Depreciation & Amortization - Total rose 4826.78% to $95821.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $221550.0, marking a year-over-year increase of 3674.32%. This contributed to the annual value of $146518.0 for FY2024, which is 3235.47% up from last year.
- Latest data reveals that Sunshine Biopharma reported Depreciation & Amortization - Total of $95821.0 as of Q3 2025, which was up 4826.78% from $72533.0 recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Depreciation & Amortization - Total ranged from a high of $95821.0 in Q3 2025 and a low of -$11597.0 during Q4 2024
- Its 5-year average for Depreciation & Amortization - Total is $27168.8, with a median of $9179.5 in 2022.
- In the last 5 years, Sunshine Biopharma's Depreciation & Amortization - Total surged by 461609.63% in 2023 and then plummeted by 39705.43% in 2024.
- Quarter analysis of 5 years shows Sunshine Biopharma's Depreciation & Amortization - Total stood at $3184.0 in 2021, then soared by 353.99% to $14455.0 in 2022, then tumbled by 72.99% to $3904.0 in 2023, then crashed by 397.05% to -$11597.0 in 2024, then skyrocketed by 926.26% to $95821.0 in 2025.
- Its last three reported values are $95821.0 in Q3 2025, $72533.0 for Q2 2025, and $64793.0 during Q1 2025.